The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.
The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.
复制标题
DOI:
10.1097/gme.0b013e3181cb49e9
复制
发表时间:
2010-05
期刊:
影响因子:
--
通讯作者:
Anderson G
中科院分区:
文献类型:
--
作者:
Edlefsen KL;Jackson RD;Prentice RL;Janssen I;Rajkovic A;O'Sullivan MJ;Anderson G
Differences in disease outcomes between users and non-users of hormone therapy (HT) and between users of estrogen alone (ET) and users of estrogen plus progesterone therapy (EPT) may relate to differences in serum hormone concentrations between these populations. In this study, we examine the response of serum hormone levels in healthy post-menopausal women after one year of HT. A representative sub-sample of 200 healthy adherent participants from the active and placebo groups of the Women's Health Initiative randomized, controlled clinical trials of ET (conjugated equine estrogen 0.625 mg daily) or EPT (ET plus medroxyprogesterone actetate 2.5 mg daily) were selected for determination of selected sex hormone levels at baseline and one year after randomization. In participants receiving active ET intervention compared to placebo, estrogenic hormone levels increased from baseline to year 1 by 3.6-fold for total estrone, 2.7-fold for total estradiol, and 1.8-fold for bioavailable and free estradiol concentrations. Serum SHBG concentrations also increased 2.5-fold. In contrast, progesterone levels decreased slightly in women taking exogenous EPT. The response of serum estrogens and SHBG did not differ substantially with the addition of progesterone. In subgroup analyses, hormone response varied by age, ethnicity, BMI, smoking, vasomotor symptoms, and baseline hormone levels. These data provide a reference point for the serum hormone response to HT, and demonstrate that response of serum estrogens is similar for ET and EPT. The implications of the slight decrease in serum progesterone levels with EPT therapy are uncertain. Potential treatment interactions for estrogenic hormones were identified, which suggest a larger response to HT in women with low endogenous levels.
登录
查看更多内容
影响因子:
2.8
作者:
Ausmanas, M. K.;Tan, D. A.;Holinka, C. F.
通讯作者:
Holinka, C. F.
影响因子:
5.8
作者:
Randolph, JF;Sowers, MF;Matthews, KA
通讯作者:
Matthews, KA
DOI:
10.1034/j.1600-0412.1999.780714.x
发表时间:
1999-08-01
影响因子:
4.3
作者:
Overlie, I;Moen, MH;Holte, A
通讯作者:
Holte, A
影响因子:
7.2
作者:
Casson, PR;ElkindHirsch, KE;Snabes, MC
通讯作者:
Snabes, MC
影响因子:
5.6
作者:
Stefanick, ML;Cochrane, BB;Johnson, SR
通讯作者:
Johnson, SR